Cell-specific delivery of a chemotherapeutic to lung cancer cells

Xin Zhou1, Ya-Ching Chang, Tsukasa Oyama

  • 1Center for Biomedical Inventions and Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9185, USA.

Insights

Lung cancer-targeting peptides deliver chemotherapy specifically to cancer cells. This targeted drug delivery enhances the therapeutic index compared to traditional systemic delivery methods.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Peptide libraries are a source of novel targeting ligands.
  • Phage display is a common method for isolating peptides with specific binding properties.
  • Targeted drug delivery aims to improve therapeutic efficacy and reduce side effects.

Purpose of the Study:

  • To develop cell-specific drug delivery systems for cancer therapy.
  • To investigate the efficacy of peptide-drug conjugates for targeted chemotherapy.
  • To assess the correlation between peptide affinity and drug efficacy.

Main Methods:

  • Isolation of lung cancer-targeting peptides from a peptide library.
  • Construction of pegylated tetrameric peptide scaffolds.
  • Coupling of doxorubicin to tetrameric peptides.
  • Evaluation of cytotoxicity against various cell lines.

Main Results:

  • Tetrameric peptides effectively targeted cancer cells and delivered doxorubicin.
  • Peptide-drug conjugates demonstrated increased cytotoxicity in a cell-specific manner.
  • Therapeutic index was improved compared to systemic doxorubicin delivery.
  • Efficacy correlated with the targeting peptide's affinity for specific cell lines.

Conclusions:

  • Lung cancer-targeting peptides can be utilized for cell-specific delivery of chemotherapeutics.
  • Peptide-drug conjugates offer a promising strategy for enhancing anticancer drug efficacy.
  • This approach enables targeted drug synthesis even without prior knowledge of cell surface targets.

Related Concept Videos

Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K